Correlation Between Merck and Biostem Technologies

Can any of the company-specific risk be diversified away by investing in both Merck and Biostem Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Biostem Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Merck Company and Biostem Technologies, you can compare the effects of market volatilities on Merck and Biostem Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Biostem Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Biostem Technologies.

Diversification Opportunities for Merck and Biostem Technologies

-0.34

Correlation Coefficient

Merck  Biostem Technologies

Very good diversification

The 3 months correlation between Merck and Biostem is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Biostem Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biostem Technologies and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Biostem Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biostem Technologies has no effect on the direction of Merck i.e., Merck and Biostem Technologies go up and down completely randomly.

Pair Corralation between Merck and Biostem Technologies

Considering the 90-day investment horizon Merck Company is expected to generate 0.19 times more return on investment than Biostem Technologies. However, Merck Company is 5.2 times less risky than Biostem Technologies. It trades about -0.01 of its potential returns per unit of risk. Biostem Technologies is currently generating about 0.0 per unit of risk. If you would invest  10,020  in Merck Company on October 11, 2024 and sell it today you would lose (35.00) from holding Merck Company or give up 0.35% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.24%
Values	Daily Returns

Merck Company  vs.  Biostem Technologies

Merck Company

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest abnormal performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Biostem Technologies

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Biostem Technologies are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, Biostem Technologies displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Merck and Biostem Technologies

The main advantage of trading using opposite Merck and Biostem Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Biostem Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biostem Technologies will offset losses from the drop in Biostem Technologies' long position.

The idea behind Merck Company and Biostem Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.